Novartis Ag (NVSEF) Capital Expenditures (QoQ) (2009 - 2026)

Novartis Ag (NVSEF) Capital Expenditures (QoQ) (2009 - 2026) Analysis & Trends

Generated on {Timestamp} © BusinessQuant.com
Generated on {Timestamp} Powered by BusinessQuant Logo

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Gsk 93,699,046.73 Bn 93,699,041.77 Bn 7.76 Bn
2 Eli Lilly 1,012.06 Bn 1,006.77 Bn 16.22 Bn
3 Johnson & Johnson 560.67 Bn 538.62 Bn 15.96 Bn
4 AbbVie 402.20 Bn 392.85 Bn 10.78 Bn
5 Merck 298.59 Bn 292.94 Bn 12.09 Bn
6 Amgen 188.77 Bn 176.74 Bn 5.87 Bn
7 Gilead Sciences 160.22 Bn 152.49 Bn 5.52 Bn
8 Pfizer 148.19 Bn 135.42 Bn -1.21 Bn
9 Bristol Myers Squibb 116.72 Bn 106.26 Bn 8.07 Bn
10 Novartis Ag - - -

Historic Data

Download Data
DateValue
Mar 31, 2026 43.19%
Dec 31, 2025 -72.03%
Sep 30, 2025 -6.95%
Jun 30, 2025 -30.31%
Mar 31, 2025 54.48%
Dec 31, 2024 -73.83%
Sep 30, 2024 -23.46%
Jun 30, 2024 -14.54%
Mar 31, 2024 44.09%
Dec 31, 2023 -55.56%
Sep 30, 2023 -16.00%
Jun 30, 2023 -33.93%
Mar 31, 2023 45.10%
Dec 31, 2022 -38.46%
Sep 30, 2022 14.01%
Jun 30, 2022 0.00%
Mar 31, 2022 44.13%
Dec 31, 2021 -31.05%
Sep 30, 2021 -9.35%
Jun 30, 2021 -30.49%